EP Patent

EP1392347B1 — Preventing cell death using segments of neural thread proteins

Assigned to Nymox Corp Canada · Expires 2005-08-03 · 21y expired

What this patent protects

Disclosed is a method of preventing, inhibiting, and/or ameliorating cell death and/or tissue necrosis in live tissue by contacting live tissue with at least a segment of NTP, or homologue, variant, derivative or mimetic thereof, where the segment of NTP, or homologue, variant, d…

USPTO Abstract

Disclosed is a method of preventing, inhibiting, and/or ameliorating cell death and/or tissue necrosis in live tissue by contacting live tissue with at least a segment of NTP, or homologue, variant, derivative or mimetic thereof, where the segment of NTP, or homologue, variant, derivative or mimetic thereof is present in an amount effective to prevent, inhibit, and/or ameliorate cell death and/or tissue necrosis. The method is capable of treating conditions requiring prevention, inhibition, and/or amelioration of cell death and/or tissue necrosis.

Drugs covered by this patent

Patent Metadata

Patent number
EP1392347B1
Jurisdiction
EP
Classification
—
Expires
2005-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Nymox Corp Canada
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.